Life
If you cap insulin at $35 a month, people with type 2 diabetes stick to treatment, study finds
Strategic angle: $35 insulin, more evidence abortion meds are safe OTC, and other health news from Morning Rounds
editorial-staff
1 min read
Updated 4 days ago
A study has found that capping insulin costs at $35 per month leads to improved adherence to treatment for individuals with type 2 diabetes.
This pricing strategy may influence overall health outcomes by ensuring more consistent access to necessary medications.
The implications for healthcare infrastructure include potential adjustments in pricing models and insurance coverage to support sustainable access to insulin.